BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/4/2023 5:53:02 AM | Browse: 317 | Download: 578
 |
Received |
|
2022-09-20 19:45 |
|
Peer-Review Started |
|
2022-09-20 19:48 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-11-26 09:10 |
|
Revised |
|
2022-11-26 19:47 |
|
Second Decision |
|
2022-12-14 04:07 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-12-14 14:42 |
|
Articles in Press |
|
2022-12-14 14:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-12-16 06:01 |
|
Publish the Manuscript Online |
|
2023-01-04 05:53 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Management of metabolic-associated fatty liver disease: The diabetology perspective
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda and Joseph M Pappachan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph M Pappachan, FRCP, MD, Professor, Senior Editor, Senior Researcher, Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust, Sharoe Green Lane, Preston PR2 9HT, United Kingdom. drpappachan@yahoo.co.in |
| Key Words |
Metabolic syndrome; Metabolic-associated fatty liver disease; Type 2 diabetes mellitus; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Diabetology perspective; Obesity |
| Core Tip |
The prevalence of metabolic-associated fatty live disease (MAFLD) and type 2 diabetes mellitus (T2DM) has increased exponentially as a consequence of the obesity pandemic across the globe. The pathobiology of T2DM and MAFLD are similar because both these disorders occur as a consequence of metabolic syndrome, and often coexist in many patients potentiating adverse outcomes and progression of individual diseases. However, the awareness about this coexistence is still inadequate even among hepatologists and diabetologists. A multidisciplinary team approach involving both the specialists is crucial in the optimal and wholistic management of both the disorders which is the theme of this comprehensive review. |
| Publish Date |
2023-01-04 05:53 |
| Citation |
Jeeyavudeen MS, Khan SKA, Fouda S, Pappachan JM. Management of metabolic-associated fatty liver disease: The diabetology perspective. World J Gastroenterol 2023; 29(1): 126-143 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i1/126.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i1.126 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
